Bayer buys into China’s lucrative TCM market
By Shannon Ellis
Wednesday, March 5, 2014
SHANGHAI – Bayer AG is buying Dihon Pharmaceutical Group Co. located China’s southwest Yunnan province. Privately held Dihon makes OTC and traditional Chinese medicines (TCM) sold in China and Southeast Asia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.